This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Colgate (CL) Poised to Beat Earnings Estimates in Q2?
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 sales are likely to have benefited from investment in brands, favorable pricing strategy, innovative product launches and enhancement of e-commerce capabilities.
Why Estee Lauder (EL) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Netflix, AstraZeneca, Union Pacific, NextEra Energy and Estee Lauder
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, AstraZeneca, Union Pacific, NextEra Energy and Estee Lauder
Top Analyst Reports for Netflix, AstraZeneca & Union Pacific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), AstraZeneca (AZN) and Union Pacific (UNP).
Estee Lauder's (EL) Robust E-commerce Business Bodes Well
by Zacks Equity Research
Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.
Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business
by Zacks Equity Research
Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.
Procter & Gamble Displays Strength on Demand for Products
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from increased demand for hand soaps, detergents and surface-cleaning products during the pandemic.
3 Factors That Make Helen of Troy (HELE) an Attractive Pick
by Zacks Equity Research
Strength in Helen of Troy's (HELE) Leadership Brands is driving growth. Moreover, the company's focus on enhancing online business is yielding.
Estee Lauder Benefits From Online Sales Amid Store Closures
by Zacks Equity Research
Estee Lauder (EL) is gaining from solid online sales amid coronavirus-led store closures. Also, the company's efficient cost-saving efforts are yielding.
Ulta Beauty Teams With Credo to Offer Clean Beauty Items
by Zacks Equity Research
Ulta Beauty's (ULTA) partnership with Credo Beauty to offer clean beauty products is likely to strengthen its footing in the evolving clean beauty space.
HELE or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
Why Is Estee Lauder (EL) Up 11.9% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Consumer Staple Stocks Set to Beat Earnings Despite Coronavirus
by Vrishali Bagree
Several players in the Consumer Staples sector have been benefiting from rising demand owing to the coronavirus-led pantry loading. We have selected five stocks with an earnings beat potential.
Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes
by Vrishali Bagree
The Cosmetics space appears to be under pressure, thanks to coronavirus-led concerns like major travel restrictions, delay in product launches and temporary store closures in some regions.
5 Consumer Staple Stocks to Trump Earnings Despite Coronavirus
by Zacks Equity Research
Several players in the Consumer Staples sector have been benefiting from increased demand owing to the coronavirus-led stockpiling. We have selected five stocks with an earnings beat potential.
Estee Lauder (EL) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures.
Estee Lauder (EL) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 18.06% and 9.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Consumer Staples Stock Earnings for May 1: CL, CLX & EL
by Rajani Lohia
Despite the havoc created by the Coronavirus pandemic, consumer staples companies look poised for gains from spiked demand for everyday essentials.
Factors Shaping the Fate of Estee Lauder's (EL) Q3 Earnings
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2020 performance is likely to reflect impacts of store closures and reduced air travel due to coronavirus. However, online sales have been aiding.
Analysts Estimate Estee Lauder (EL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums Q1 Sales Soft, Launches Delayed Amid Coronavirus
by Zacks Equity Research
Inter Parfums (IPAR) reports dismal sales numbers in first-quarter 2020. Also, the company postponed launches due to growing coronavirus concerns.
Estee Lauder Shuts Stores, Draws for Credit Amid Coronavirus Fears
by Zacks Equity Research
Estee Lauder Companies (EL) shuts most stores in the Americas, Europe, Middle East & Africa region amid the coronavirus outbreak. Also, air travel is restricted.
Moving Average Crossover Alert: Estee Lauder
by Zacks Equity Research
The Estee Lauder Companies Inc. (EL) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Inter Parfums (IPAR) Withdraws 2020 View Due to Coronavirus
by Zacks Equity Research
Due to the coronavirus outbreak and its impact on revenues and costs, Inter Parfums (IPAR) has withdrawn full-year 2020 guidance.
Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?
by Zacks Equity Research
Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.